Private equity investors are making bigger bets in Asia’s healthcare sector

In 2018, when Navis Capital Partners acquired the Australian medical device company Device Technologies for over $508.7 million (A$700 million), it raised several eyebrows. Reason? Not only did it mark the biggest transaction for the Kuala Lumpur-headquartered private equity (PE) firm, it also paved the way for one of most notable exits for its earlier investor Pemba Capital Partners.

Continue reading this story with a subscription to DealStreetAsia.


Contact us for corporate subscriptions at